Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome

Prenatal Diagnosis

Volumn 32, Issue 7, 2012, Pages 638-643

  Karadzov Orlic, Natasa ^a   Egic, Amira ^a   Milovanovic, Zagorka ^a   Marinkovic, Maja ^a   Damnjanovic Pazin, Barbara ^a   Lukic, Relja ^a   Joksic, Ivana ^a   Curkovic, Aleksandar ^a   Mikovic, Zeljko ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; DUCTUS VENOSUS; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TRICUSPID VALVE REGURGITATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME; VEIN BLOOD FLOW;

ADULT; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CORONARY CIRCULATION; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY; TRISOMY; TURNER SYNDROME; ULTRASONOGRAPHY, PRENATAL; UMBILICAL VEINS;

EID: 84863433042     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3873     Document Type: Article

References (20)

1. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
2. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-6.
3. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14weeks using fetal nuchal translucency, maternal serum free beta human chorionic gonadotropin and pregnancy-associated plasma protein A. Ultrasound Obstet Gynecol 1999;13:231-7.
4. Spencer K, Spencer CE, Power M. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynecol 2003;107:1271-5.
5. Kagan KO, Staboulidou I, Cruz J, Wright D, Nicolaides KH. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 2010;36:542-7.
6. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008;31:376-83.
7. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13weeks gestation. Ultrasound Obstet Gynecol 2009a;33:259-64.
8. Maiz N, Kagan KO, Milovanovic Z, Elik E, Nicolaides KH. Learning curve for Doppler assessment of ductus venosus flow at 11-13+6 weeks. Ultrasound Obstet Gynecol 2008;31:503-6.
9. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tricuspid regurgitation at 11+0 to 13+6week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006;27:609-12.
10. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6weeks of gestation. Ultrasound Obstet Gynecol 2009b;33:18-22.
11. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008a; 31:493-502.
12. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7-15.
13. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008b;33:1968-75.
14. Wright D, Spencer K, Kagan K, Torring N, Petersen O.B, Christou A. First-trimester combined screening for trisomy 21 at 7-14weeks gestation. Ultrasound Obstet Gynecol 2010;36:404-11.
15. van Ravenswaai R, Tesselaar-van der Goot M, de Wolf S, van Leeuwen-Spruijt M. Visser G.H.A, Schielen PCJI. First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome. Prenat Diagn 2011;31:50-7.
16. Cicero S, Rembouskos G, Vandercruys G, Hogg M, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14week scan. Ultrasound Obstet Gynecol 2004;23:218-23.
17. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18, 13 and Turner syndrome at 11-13weeks gestation. Ultrasound Obstet Gynecol 2009;33:512-7.
18. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6weeks of gestation. Ultrasound Obstet Gynecol 2009c;33:18-22.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression (2nd edn). John Wiley & Sons, Inc.: Hoboken, NJ. 2000;156-64.
20. Agresti A. Categorical Data Analysis (2nd edn). John Wiley & Sons, Inc.: Hoboken, NJ. 2002;228-30.